 Role prostaglandin pulmonary vascular resistance experimental model acute lung injury role efficacy prostaglandin cardiopulmonary derangements glass bead embolism studies first study dose response animals sufficient glass beads pulmonary artery pressure PAP study PAP cardiac output preload-mediated mechanism reduction right ventricular RV end-diastolic segment length doses ng/kg.min second study groups animals control group group ng/kg.min PAP glass bead embolism RV preload constant study difference pulmonary vascular resistance treated group control group significant differences groups results studies little afterload effect model dose ranges Part mechanism pulmonary edema gas exchange reduction filtration surface area hydrostatic pressures lungs